Hannu Alho

10.3k total citations · 1 hit paper
225 papers, 8.1k citations indexed

About

Hannu Alho is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Hannu Alho has authored 225 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 60 papers in Cellular and Molecular Neuroscience and 51 papers in Epidemiology. Recurrent topics in Hannu Alho's work include Substance Abuse Treatment and Outcomes (37 papers), Neuroscience and Neuropharmacology Research (36 papers) and Opioid Use Disorder Treatment (32 papers). Hannu Alho is often cited by papers focused on Substance Abuse Treatment and Outcomes (37 papers), Neuroscience and Neuropharmacology Research (36 papers) and Opioid Use Disorder Treatment (32 papers). Hannu Alho collaborates with scholars based in Finland, United States and United Kingdom. Hannu Alho's co-authors include E. Costa, Alessandro Guidotti, Sari Castrén, Anne H. Salonen, Janne Leinonen, Ferdinando Nicoletti, Antonello Novelli, A M Szekely, Kari Poikolainen and Jouko Lönnqvist and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Hannu Alho

215 papers receiving 7.7k citations

Hit Papers

The activation of inositol phospholipid metabolism as a s... 1986 2026 1999 2012 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannu Alho Finland 47 2.7k 2.6k 1.3k 915 871 225 8.1k
William Slikker United States 60 3.8k 1.4× 2.7k 1.0× 505 0.4× 824 0.9× 559 0.6× 329 13.3k
Simon Scharpé Belgium 59 2.3k 0.9× 2.3k 0.9× 592 0.5× 835 0.9× 371 0.4× 190 11.7k
Stefan Bleich Germany 51 795 0.3× 2.1k 0.8× 836 0.7× 1.0k 1.1× 1.2k 1.4× 329 7.8k
Michael G. Ziegler United States 71 2.2k 0.8× 3.0k 1.1× 857 0.7× 4.2k 4.6× 1.1k 1.2× 407 17.0k
Brian Pittman United States 58 2.3k 0.8× 1.5k 0.6× 697 0.5× 694 0.8× 1.5k 1.7× 264 9.5k
Peter Jatlow United States 48 2.1k 0.8× 1.5k 0.6× 808 0.6× 1.1k 1.2× 464 0.5× 161 6.6k
Manfred Uhr Germany 57 1.1k 0.4× 1.7k 0.7× 508 0.4× 1.2k 1.3× 1.1k 1.2× 199 10.2k
Martin A. Javors United States 48 2.1k 0.8× 4.0k 1.5× 1.6k 1.3× 3.4k 3.7× 543 0.6× 165 11.6k
Alan Wayne Jones Sweden 48 2.0k 0.8× 2.2k 0.8× 1.2k 0.9× 963 1.1× 390 0.4× 345 9.9k
Garry Jennings Australia 79 872 0.3× 2.4k 0.9× 981 0.8× 3.2k 3.5× 444 0.5× 425 21.4k

Countries citing papers authored by Hannu Alho

Since Specialization
Citations

This map shows the geographic impact of Hannu Alho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannu Alho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannu Alho more than expected).

Fields of papers citing papers by Hannu Alho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannu Alho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannu Alho. The network helps show where Hannu Alho may publish in the future.

Co-authorship network of co-authors of Hannu Alho

This figure shows the co-authorship network connecting the top 25 collaborators of Hannu Alho. A scholar is included among the top collaborators of Hannu Alho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannu Alho. Hannu Alho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiwach, Rajinder, Bernard Le Foll, Hannu Alho, et al.. (2025). Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use. JAMA Network Open. 8(12). e2548043–e2548043.
2.
Shiwach, Rajinder, Bernard Le Foll, Hannu Alho, et al.. (2025). Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine. JAMA Network Open. 8(10). e2537319–e2537319. 2 indexed citations
4.
Addolorato, Giovanni, et al.. (2024). Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.. European Journal of Internal Medicine. 127. 43–49. 1 indexed citations
5.
Alho, Hannu, et al.. (2021). Intranasal as needed naloxone in the treatment of gambling disorder: A randomised controlled trial. Addictive Behaviors. 125. 107127–107127. 9 indexed citations
6.
Kraus, M., Nicholas Lintzeris, Arun Bhaskar, et al.. (2019). Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder. Journal of Addiction Medicine. 14(1). 1–11. 36 indexed citations
7.
Alho, Hannu, et al.. (2017). Opioidikorvaushoito on laajentunut ja monimuotoistunut. Työväentutkimus Vuosikirja. 72. 2981–2985. 1 indexed citations
8.
Stenius, Kerstin, et al.. (2015). Opioidikorvaushoito Suomessa ja muissa Pohjoismaissa: vakiintunut hoitomuoto mutta vaihteleva käytäntö. 70(19). 1343–1348. 1 indexed citations
9.
Rehm, Jürgen, Maximilien X. Rehm, Hannu Alho, et al.. (2013). Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland. The International Journal of Alcohol and Drug Research. 2(2). 53–67. 21 indexed citations
10.
Lahti, Jari, Hannu Alho, Leena Kovanen, et al.. (2013). mu-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
11.
Castrén, Sari, et al.. (2013). Factors associated with disordered gambling in Finland. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 4 indexed citations
12.
13.
Halme, Jukka, Kaija Seppä, Hannu Alho, et al.. (2010). Alcohol consumption and all-cause mortality among elderly in Finland. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 2 indexed citations
14.
Simojoki, Kaarlo & Hannu Alho. (2010). Urine Labelling Marker System for Drug Testing Improves Patient Compliance. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 12(1). 25–32. 1 indexed citations
15.
Aalto, Mauri, Hannu Alho, Jukka Halme, & Kaija Seppä. (2009). AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 2 indexed citations
16.
Halme, Jukka, Kaija Seppä, Hannu Alho, et al.. (2009). Alcohol consumption and all-cause mortality among elderly in Finland. Drug and Alcohol Dependence. 106(2-3). 212–218. 34 indexed citations
17.
Crohns, Marika, Kari Liippo, Marina Erhola, et al.. (2009). Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer. Clinical Biochemistry. 42(12). 1236–1245. 23 indexed citations
18.
Lönnqvist, Jouko, et al.. (2008). Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence. The Journal of Clinical Psychiatry. 69(3). 392–399. 98 indexed citations
19.
Rothstein, J.D., et al.. (2001). Microglial response to the neurotoxicity of 6‐hydroxydopamine in neonatal rat cerebellum. International Journal of Developmental Neuroscience. 19(1). 47–52. 5 indexed citations
20.
Sillanaukee, Pekka, Pekka Sillanaukee, Hannu Alho, et al.. (2000). Effect of Hormone Balance on Carbohydrate‐Deficient Transferrin and Gamma‐Glutamyltransferase in Female Social Drinkers. Alcoholism Clinical and Experimental Research. 24(10). 1505–1509. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026